NCT01684917 Application of New Technologies and Tools to Nutrition Research Status COMPLETED Phase NA
NCT01684722 Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease Status COMPLETED Phase NA
NCT01682902 A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01680341 Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine Status COMPLETED Phase PHASE3
NCT01680328 Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations Status COMPLETED Phase PHASE1
NCT01679210 Study of a Postpartum Diabetes Prevention Program for Hispanic Women Status COMPLETED Phase NA
NCT01676116 The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy Status COMPLETED Phase PHASE3
NCT01671735 VA Diabetes Prevention: Epidemiology of Pre-Diabetes and Implementation Pilot Status WITHDRAWN Phase NA
NCT01664247 The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification Status COMPLETED Phase PHASE3
NCT01663298 Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics Status COMPLETED Phase N/A
NCT01654172 Effect of Flavanol-rich Cocoa on Peripheral and Cerebral Blood Flow in Type 2 Diabetes Status COMPLETED Phase NA
NCT01653951 Comparative Effectiveness of Two Approaches to Diabetes Management in the Uninsured Status COMPLETED Phase NA
NCT01650129 Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01647438 Translating a Heart Disease Lifestyle Intervention Into the Community Status COMPLETED Phase NA
NCT01645696 Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics Status COMPLETED Phase NA